Identification of causal genetic mutations for the early diagnosis of Parkinson's Disease
- Summary
- Asa Abeliovich, M.D., Ph.D.
- Technology Benefits
- Identifies causal factors of Parkinson's Disease and provides a potential biomarker for the diagnosis of disease as well as therapeutic approaches.Employs a methodology that can serve as a platform for the study of multiple other diseases, including other neurodegenerative disorders.Patent information:Patent Pending (WO/2013/086041)Tech Ventures Reference: IR 2837
- Technology Application
- Identifies genetic biomarkers that could aid in the diagnosis of Parkinson's Disease.Potential application as a pathological identifier in other diseases that result from transcription errors or neural degeneration.
- Detailed Technology Description
- Asa Abeliovich, M.D., Ph.D.
- *Abstract
-
None
- *Inquiry
- Jerry KokoshkaColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 2837
- *Principal Investigator
-
- *Publications
- H. Rhinn, L. Qiang, T. Yamashita, D. Rhee, Z. Zolin, W. Vanti, A. Abeliovich. Alternative a-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. Nature Communications, Vol. 3, 2012, 1084.
- Country/Region
- USA
For more information, please click Here

